|1.||Odom, Samuel L: 2 articles (02/2014 - 04/2010)|
|2.||Boyd, Brian A: 2 articles (02/2014 - 04/2010)|
|3.||Hume, Kara: 2 articles (02/2014 - 04/2010)|
|4.||Daidone, Maria G: 1 article (01/2015)|
|5.||Di Cosimo, Serena: 1 article (01/2015)|
|6.||Bianchi, Giulia: 1 article (01/2015)|
|7.||Motta, Rosita: 1 article (01/2015)|
|8.||Martinetti, Antonia: 1 article (01/2015)|
|9.||Wechsler, Janine: 1 article (01/2015)|
|10.||Cappelletti, Vera: 1 article (01/2015)|
03/01/2012 - "Broader availability of a CTMS might help improve patient participation in cancer clinical trials."
03/01/2012 - "The American Cancer Society (ACS) and Coalition of Cancer Cooperative Groups (CCCG) provide a clinical trial (CT) information/matching/eligibility service (Clinical Trials Matching Service [CTMS]). "
01/01/2015 - "Circulating tumor microemboli (CTMs) were detected in addition to single CTCs with significantly higher frequency in M0 than M+ samples (78% vs. 27%, p = 0.0002). "
08/09/2013 - "The presence of CTCs and other two forms of occult disease including circulating tumor microembolus (CTMs) as well as disseminated tumor cells (DTCs) as a sign for micrometastasis has been associated with adverse survival of both localized and metastatic cancers. "
08/01/2013 - "In addition, a new _ISET-based device could be designed to increase sensitivity to CTCs/CTMs greatly and reduce the number of CTCs/CTMs directly during the blood flow, thus decreasing the _possibility of tumor recurrence and metastasis while retaining normal blood cells. "
|2.||Circulating Neoplastic Cells
08/01/2013 - "Current technologies to identify and characterize circulating tumor cells (CTCs) and _ circulating tumor microemboli (CTMs) among hundreds of millions of leukocytes in the bloodstream can be classified into tumor-marker-dependent and -independent technology. "
01/01/2013 - "Single circulating tumor cells (CTCs) or circulating tumor microemboli (CTMs) are potential biomarkers of renal cell cancer (RCC), however studies of CTCs/CTMs in RCC are limited. "
|3.||Renal Cell Carcinoma (Grawitz Tumor)
|4.||Autistic Disorder (Autism)
01/01/2014 - "This study was undertaken to test the hypothesis that repetitive transcranial magnetic stimulation (rTMS) using a neuronavigational TMS system (nTMS) to the Broca's area would elicit greater virtual aphasia than rTMS using the conventional TMS method (cTMS). "
01/01/2014 - "Eighteen healthy subjects underwent a randomized crossover experiment to induce virtual aphasia by targeting the Brodmann area 44 and 45 for nTMS, and F3 of international 10-20 system for cTMS. "
|1.||Biological Markers (Surrogate Marker)